Medicare Enrolled

Dr. Scott Gold, MD

Neurology · Melbourne, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1223 GATEWAY DR STE 2G, Melbourne, FL 32901
3214736160
Registered in NPPES since 2006
NPI: 1578522058 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gold from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gold? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gold

Dr. Scott Gold is a neurology specialist in Melbourne, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gold performed 456 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Gold received a total of $303,034 from 63 pharmaceutical and/or device companies across 1076 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gold is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 456 Medicare services $303,034 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 42130 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
456
Medicare services
Bottom 47% in FL for neurology
Not available
Unique patients (not deduplicated)
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
356 $85 $255
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
85 $132 $358
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $66 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$303,034
Total received (2018-2024)
Avg $43,291/year across 7 years
Top 2% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
1,076
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,271
2023
$1,114
2022
$25,545
2021
$43,648
2020
$34,304
2019
$80,815
2018
$115,337

Payments by company (2024)

TG Therapeutics, Inc.
$1,937
EMD Serono, Inc.
$198
GENZYME CORPORATION
$78
Genentech USA, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$23
Top 3 companies account for 97.5% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$98,280
Biogen, Inc.
$60,627
EMD Serono, Inc.
$53,074
Genentech USA, Inc.
$42,048
Teva Pharmaceuticals USA, Inc.
$12,972
E.R. Squibb & Sons, L.L.C.
$11,465
Celgene Corporation
$8,115
Genentech, Inc.
$4,430
Novartis Pharmaceuticals Corporation
$3,113
TG Therapeutics, Inc.
$1,937
Avanir Pharmaceuticals, Inc.
$545
Sunovion Pharmaceuticals Inc.
$429
Alexion Pharmaceuticals, Inc.
$414
ABBVIE INC.
$379
Amgen Inc.
$370
UCB, Inc.
$332
Lilly USA, LLC
$297
Supernus Pharmaceuticals, Inc.
$284
AbbVie Inc.
$244
Acorda Therapeutics, Inc
$243
Greenwich Biosciences, Inc.
$177
Biohaven Pharmaceuticals, Inc.
$172
Lundbeck LLC
$169
ACADIA Pharmaceuticals Inc
$161
IDORSIA PHARMACEUTICALS US INC
$150
Allergan, Inc.
$140
SANOFI-AVENTIS U.S. LLC
$128
Adamas Pharmaceuticals, Inc.
$123
Eisai Inc.
$123
Bayer HealthCare Pharmaceuticals Inc.
$120
Kyowa Kirin, Inc.
$114
US WorldMeds, LLC
$112
Janssen Pharmaceuticals, Inc
$112
Takeda Pharmaceuticals U.S.A., Inc.
$107
Otsuka America Pharmaceutical, Inc.
$106
Allergan Inc.
$106
TG THERAPEUTICS, INC.
$105
EISAI INC.
$95
SK Life Science, Inc.
$86
Mallinckrodt Enterprises LLC
$83
Grifols USA, LLC
$82
Neurocrine Biosciences, Inc.
$70
Neurelis, Inc.
$66
Horizon Therapeutics plc
$63
Mallinckrodt LLC
$63
GE HEALTHCARE
$59
Ipsen Biopharmaceuticals, Inc
$59
Mallinckrodt Hospital Products Inc.
$54
AbbVie, Inc.
$48
PFIZER INC.
$46
PORTOLA PHARMACEUTICALS, INC.
$44
LivaNova USA, Inc.
$41
Almatica Pharma LLC
$39
Assertio Therapeutics, Inc.
$31
Amneal Pharmaceuticals LLC
$31
BANNER LIFE SCIENCES, LLC
$30
CATALYST PHARMACEUTICALS, INC.
$23
Alnylam Pharmaceuticals Inc.
$20
Biohaven Pharmaceutical Holding Company Ltd.
$19
Merz North America, Inc.
$18
Exeltis, USA Inc.
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$13
BOSTON SCIENTIFIC CORPORATION
$13
Top 3 companies account for 70.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Aimovig · BAFIERTAM · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · Enspryng · Epidiolex · Evrysdi · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · HYQVIA · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LYRICA · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONFI · ONPATTRO · Ocrevus · Ozanimod · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · Vimpat · XEOMIN · Xadago · ZEPOSIA · ZERIT
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Melbourne?
Compare neurologists in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
30
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
HOLMES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gold is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gold experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gold performed 356 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gold receive payments from pharmaceutical companies?
Yes. Dr. Gold received a total of $303,034 from 63 companies across 1,076 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gold's costs compare to other neurologists in Melbourne?
Dr. Gold's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gold) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →